ResearcherAzienda Ospedaliera Sant'AndreaNo recent work listed
Matteo Piciucchi
Matched on ORCID iD 0000-0002-9359-4789; OpenAlex author ID A5066695507. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2015: 1 paper · 2016: none · 2017: 2 papers
Papers 3
- Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study. First author DOI 10.1038/s41598-017-13430-z↗
- The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. Co-author DOI 10.3390/ijms18040730↗
- Early onset pancreatic cancer: risk factors, presentation and outcome. Co-author DOI 10.1016/j.pan.2015.01.013↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gianfranco Delle Fave · 3 shared papers, 2015–2017 · strength 0.18
- Paper The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer … DOI 10.3390/ijms18040730↗
- Paper Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study. DOI 10.1038/s41598-017-13430-z↗
- Paper Early onset pancreatic cancer: risk factors, presentation and outcome. DOI 10.1016/j.pan.2015.01.013↗
- Roberto Valente · 3 shared papers, 2015–2017 · strength 0.18
- Paper The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer … DOI 10.3390/ijms18040730↗
- Paper Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study. DOI 10.1038/s41598-017-13430-z↗
- Paper Early onset pancreatic cancer: risk factors, presentation and outcome. DOI 10.1016/j.pan.2015.01.013↗
- Lívia Archibugi · 3 shared papers, 2015–2017 · strength 0.18
- Paper The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer … DOI 10.3390/ijms18040730↗
- Paper Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study. DOI 10.1038/s41598-017-13430-z↗
- Paper Early onset pancreatic cancer: risk factors, presentation and outcome. DOI 10.1016/j.pan.2015.01.013↗
- Gabriele Capurso · 3 shared papers, 2015–2017 · strength 0.18
- Paper The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer … DOI 10.3390/ijms18040730↗
- Paper Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study. DOI 10.1038/s41598-017-13430-z↗
- Paper Early onset pancreatic cancer: risk factors, presentation and outcome. DOI 10.1016/j.pan.2015.01.013↗
- Marianna Signoretti · 2 shared papers, 2015–2017 · strength 0.11
- Patrick Maisonneuve · 1 shared paper, 2017 · strength 0.07
- Michèle Milella · 1 shared paper, 2017 · strength 0.07
- Vincenzo Ziparo · 1 shared paper, 2015 · strength 0.04
- Alberto Larghi · 1 shared paper, 2015 · strength 0.04
- Marco La Torre · 1 shared paper, 2015 · strength 0.04
- Guido Costamagna · 1 shared paper, 2015 · strength 0.04
- Paolo Marchetti · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.